Loading...
Market
How will Sanofi's investment affect China-EU trade relations by 2025?
2
Resolution / Starting Odds
Improved relations • 25%
No change • 25%
Worsened relations • 25%
Other • 25%
Analyses from reputable financial and trade publications
Story
Sanofi to Invest €1 Billion ($1.05 Billion) in Fourth Beijing Insulin Production Base Amid China-EU Trade Tensions
Dec 2, 2024, 09:14 PM
Sanofi, the French pharmaceutical giant, has announced plans to invest approximately 1 billion euros (around $1.05 billion) to establish a new insulin production facility in Beijing. This investment represents Sanofi's largest single investment in China to date and marks a significant move amid ongoing trade tensions between China and the European Union. The new manufacturing base will be Sanofi's fourth production and supply site in the country. The announcement was made following a memorandum of understanding signed recently, highlighting the company's commitment to expanding its operations in the region.
View original story
Similar markets
Project halted • 25%
Project delayed • 25%
Project unaffected • 25%
Project expedited • 25%
Less than 5% increase • 25%
5% to 10% increase • 25%
10% to 15% increase • 25%
More than 15% increase • 25%
Increase by over 10% • 25%
Increase by 5-10% • 25%
Increase by less than 5% • 25%
No significant change • 25%
Yes • 50%
No • 50%
Significant deterioration • 25%
Minor deterioration • 25%
No change • 25%
Improvement • 25%
Less than 500 • 25%
500 to 1000 • 25%
1000 to 1500 • 25%
More than 1500 • 25%
Yes • 50%
No • 50%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
€1.3B or less • 25%
More than €1.3B to €1.5B • 25%
More than €1.5B to €1.7B • 25%
More than €1.7B • 25%